Ossium Health entered into a collaborative agreement with Extremity Medical for the distribution of OssiGraft viable bone matrix.
OssiGraft allograft is derived from the vertebral bones of organ donors and is intended for use in orthopedic surgery to support the reconstruction or repair of musculoskeletal defects or injuries. The product is derived from a younger donor demographic than other bone allografts on the market and is characterized by a high cancellous bone ratio for optimal bone healing.
Extremity Medical also announced the successful completion of the initial cases with OssiGraft. The product is now available throughout the U.S.
Ossium Health entered into a collaborative agreement with Extremity Medical for the distribution of OssiGraft viable bone matrix.
OssiGraft allograft is derived from the vertebral bones of organ donors and is intended for use in orthopedic surgery to support the reconstruction or repair of musculoskeletal defects or injuries. The product is...
Ossium Health entered into a collaborative agreement with Extremity Medical for the distribution of OssiGraft viable bone matrix.
OssiGraft allograft is derived from the vertebral bones of organ donors and is intended for use in orthopedic surgery to support the reconstruction or repair of musculoskeletal defects or injuries. The product is derived from a younger donor demographic than other bone allografts on the market and is characterized by a high cancellous bone ratio for optimal bone healing.
Extremity Medical also announced the successful completion of the initial cases with OssiGraft. The product is now available throughout the U.S.
Copy to clipboard 
